Literature DB >> 25135100

Is systemic inflammation not involved in endoscopic duodenal-jejunal bypass liner-induced diabetes remission?

Cheng-I Wu1, Wei-Jei Lee, Chih-Yen Chen.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25135100     DOI： 10.1007/s11695-014-1399-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  12 in total

Review 1.  Cachexia and herbal medicine: perspective.

Authors:  Hajime Suzuki; Akihiro Asakawa; Haruka Amitani; Norifumi Nakamura; Akio Inui
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans.

Authors:  Chih-Yen Chen; Mineko Fujimiya; Alessandro Laviano; Full-Young Chang; Han-Chieh Lin; Shou-Dong Lee
Journal:  J Chin Med Assoc       Date:  2010-05       Impact factor: 2.743

3.  Intracerebroventricular O-n-octanoylated ghrelin and its splice variant-induced feeding is blocked by insulin, independent of obestatin or CRF receptor, in satiated rats.

Authors:  Chih-Yen Chen; Chang-Youh Tsai; Wei-Jei Lee; Wen-Jinn Liaw; Chi-Huei Chiang; Shung-Tai Ho; Shou-Dong Lee
Journal:  Nutrition       Date:  2012-03-30       Impact factor: 4.008

4.  Insulin secretion and interleukin-1β dependent mechanisms in human diabetes remission after metabolic surgery.

Authors:  Chih-Yen Chen; Wei-Jei Lee; A Asakawa; N Fujitsuka; Keong Chong; Shu-Chun Chen; Shou-Dong Lee; A Inui
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

Authors:  Charlotte de Jonge; Sander S Rensen; Froukje J Verdam; Royce P Vincent; Steve R Bloom; Wim A Buurman; Carel W le Roux; Nicolaas C Schaper; Nicole D Bouvy; Jan Willem M Greve
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

6.  Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study.

Authors:  Maren Carstensen; Christian Herder; Mika Kivimäki; Markus Jokela; Michael Roden; Martin J Shipley; Daniel R Witte; Eric J Brunner; Adam G Tabák
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

7.  Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus.

Authors:  Wei-Jei Lee; Chih-Yen Chen; Kong-Han Ser; Keong Chong; Shu-Chun Chen; Pui-Ching Lee; You-Di Liao; Shou-Dong Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Purinergic P2X7 receptors regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival.

Authors:  R Glas; N S Sauter; F T Schulthess; L Shu; J Oberholzer; K Maedler
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

9.  Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Authors:  Christian Herder; Eric J Brunner; Wolfgang Rathmann; Klaus Strassburger; Adam G Tabák; Nanette C Schloot; Daniel R Witte
Journal:  Diabetes Care       Date:  2008-12-10       Impact factor: 19.112

10.  Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Authors:  Claus M Larsen; Mirjam Faulenbach; Allan Vaag; Jan A Ehses; Marc Y Donath; Thomas Mandrup-Poulsen
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.